HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-acting local anesthetics attenuate FMLP-induced acute lung injury in rats.

AbstractBACKGROUND:
Endothelin-1 (ET-1) is a mediator of lung diseases and a potent pulmonary vasoconstrictor. In addition to thromboxane A2, it participates in the formation of lung edema. Both lidocaine and mepivacaine attenuate the increase of pulmonary arterial pressure (PAP) and lung edema development. We examined the effects of procaine, bupivacaine, and ropivacaine on experimentally evoked PAP increase and ET-1 release.
METHODS:
PAP and lung weight were measured in isolated rat lungs during perfusion with Krebs-Henseleit hydroxyethyl starch buffer. Bupivacaine, ropivacaine, or procaine was added to the solution at concentrations of 10(-2)-10(-7) mg/kg. ET-1 levels were measured in the perfusate by enzyme-immunoassay, and thromboxane A2 levels were assayed by radioimmunoassay. N-formyl-L-leucine-methionyl-L-phenylalanine was used to activate human polymorphonuclear neutrophils.
RESULTS:
Bupivacaine, ropivacaine, and procaine significantly attenuated increases of PAP (P < 0.05) and resulted in a reduction of lung weight in these treatment groups compared with the sham group (P < 0.05). The long-acting anesthetics bupivacaine and ropivacaine (P < 0.05), but not procaine, reduced ET-1 levels, produced low inflammation rates, and did not affect lung structures at doses from 10(-3) to 10(-6) mg/kg.
CONCLUSION:
Bupivacaine and ropivacaine attenuated N-formyl-L-leucine-methionyl-L-phenylalanine-induced PAP, reduced lung edema, and diminished ET-1 release. Lidocaine and mepivacaine are more effective in reducing PAP and edema formation, but long-acting local anesthetics also inhibit ET-1 depletion and therefore have increased anti-inflammatory properties.
AuthorsMarcus T Schley, Matthias Casutt, Christoph Haberthür, Martin Dusch, Roman Rukwied, Martin Schmelz, Joachim Schmeck, Guido K Schüpfer, Christoph J Konrad
JournalAnesthesia and analgesia (Anesth Analg) Vol. 109 Issue 3 Pg. 880-5 (Sep 2009) ISSN: 1526-7598 [Electronic] United States
PMID19690261 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amides
  • Anti-Inflammatory Agents
  • Endothelin-1
  • Vasoconstrictor Agents
  • Thromboxane A2
  • N-Formylmethionine Leucyl-Phenylalanine
  • Ropivacaine
  • Lidocaine
  • Mepivacaine
  • Bupivacaine
Topics
  • Acute Lung Injury (chemically induced, drug therapy)
  • Amides (pharmacology)
  • Anesthesia, Local (methods)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Bupivacaine (pharmacology)
  • Endothelin-1 (biosynthesis)
  • Female
  • Granulocytes (metabolism)
  • Lidocaine (pharmacology)
  • Male
  • Mepivacaine (pharmacology)
  • N-Formylmethionine Leucyl-Phenylalanine (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Ropivacaine
  • Thromboxane A2 (metabolism)
  • Vasoconstrictor Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: